Regulus TherapeuticsRGLS
13F holders, Q1 2024 (March 31)44holders
2famous investors
$2.82avg. 13F price*
At the end of Q1 2024, 44 institutions reported holding Regulus Therapeutics Inc. (RGLS) in their 13F filings. The largest holders were Federated Hermes, Inc. ($34.4M), Ra Capital Management, L.P. ($18.0M) and Vivo Capital, LLC ($14.4M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Regulus Therapeutics Inc.
- CUSIP
- 75915K309
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 22 | $76.2M |
| Exits | 3 | $36K |
Ownership 44 holders
| Federated Hermes, Inc. | 0.08% | Add +231.6% | 12,852,654 | $34.4M |
| Ra Capital Management, L.P. | 0.23% | New | 6,250,000 | $18.0M |
| Vivo Capital, LLC | 1.13% | New | 5,000,000 | $14.4M |
| Adage Capital Partners Gp, L.L.C. | 0.02% | New | 3,679,854 | $10.6M |
| Deep Track Capital, LP | 0.27% | New | 3,266,566 | $9.4M |
| FMR LLC | 0.00% | No change | 2,922,600 | $8.4M |
| Millennium Management | 0.00% | New | 1,875,226 | $5.4M |
| Soleus Capital Management, L.P. | 0.40% | New | 1,562,500 | $4.5M |
| CVI Holdings, LLC | 3.89% | New | 1,406,250 | $4.0M |
| DAFNA Capital Management LLC | 0.71% | Reduce -3.6% | 1,070,548 | $3.1M |
| Alyeska Investment Group, L.P. | 0.02% | New | 937,500 | $2.7M |
| Vanguard Group Inc. | 0.00% | Add +158.4% | 740,215 | $2.1M |
| Monashee Investment Management LLC | 0.22% | New | 625,000 | $1.8M |
| Hudson Bay Capital Management LP | 0.02% | New | 625,000 | $1.7M |
| Polar Asset Management Partners Inc. | 0.06% | New | 536,400 | $1.5M |
| Exome Asset Management LLC | 0.99% | Add +125.6% | 402,504 | $1.2M |
| Victory Capital Management Inc. | 0.00% | Add +35.5% | 368,146 | $1.1M |
| Goldman Sachs Group Inc. | 0.00% | New | 227,419 | $655K |
| Sarissa Capital Management LP | 0.09% | No change | 185,183 | $533K |
| Opaleye Management Inc. | 0.11% | New | 170,308 | $490K |
| Geode Capital Management, LLC | 0.00% | Add +31.1% | 160,590 | $463K |
| Prelude Capital Management, LLC | 0.03% | Add +229.0% | 132,470 | $382K |
| LPL Financial LLC | 0.00% | New | 113,480 | $327K |
| Simplex Trading, LLC | 0.01% | New | 75,450 | $217K |
| Renaissance Technologies | 0.00% | Add +38.3% | 75,500 | $217K |
| BlackRock Inc. | 0.00% | Add +11772.8% | 68,031 | $196K |
| HRT Financial LP | 0.00% | New | 62,797 | $180K |
| State Street Corp. | 0.00% | No change | 41,719 | $120K |
| Morgan Stanley | 0.00% | New | 27,819 | $80K |
| Balyasny Asset Management L.P. | 0.00% | New | 24,253 | $70K |
| Susquehanna International Group, LLP | 0.00% | New | 22,528 | $65K |
| JPMorgan Chase & Co. | 0.00% | Add +67975.9% | 19,742 | $57K |
| CTC Alternative Strategies, Ltd. | 0.03% | New | 18,500 | $53K |
| Commonwealth Equity Services, LLC | 0.00% | Add +2.9% | 18,000 | $52K |
| Northern Trust Corp. | 0.00% | No change | 17,978 | $52K |
| Citigroup Inc. | 0.00% | Add +567.3% | 14,167 | $41K |
| GRIMES & Co WEALTH MANAGEMENT, LLC | 0.00% | Reduce -1.5% | 10,264 | $30K |
| Group One Trading LLC | 0.00% | New | 8,607 | $25K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +18794.1% | 3,212 | $9K |
| Community Bank, N.A. | 0.00% | No change | 690 | $2K |
| UBS Group AG | 0.00% | Reduce -12.2% | 302 | $870 |
| Wells Fargo & Company | 0.00% | Add +1.4% | 142 | $409 |
| Macquarie Group Ltd. | 0.00% | New | 865 | $2 |
| Royal Bank of Canada | 0.00% | Reduce -36.3% | 51 | $0 |
"% of holder's portfolio" is RGLS's weight in each manager's 13F, not the share of Regulus Therapeutics Inc. the manager owns.